|
C20ORF72 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.64410000455828E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.156630E-04 |
| Normal-vs-Stage2 |
1.584980E-03 |
| Normal-vs-Stage3 |
1.511780E-02 |
| Normal-vs-Stage4 |
4.236500E-02 |
| Stage1-vs-Stage2 |
3.340800E-01 |
| Stage1-vs-Stage3 |
8.308600E-01 |
| Stage1-vs-Stage4 |
7.063000E-01 |
| Stage2-vs-Stage3 |
4.941800E-01 |
| Stage2-vs-Stage4 |
7.279200E-01 |
| Stage3-vs-Stage4 |
8.236000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.67160000180888E-08 |
| Normal-vs-AfricanAmerican |
1.312470E-02 |
| Normal-vs-Asian |
1.079630E-01 |
| Caucasian-vs-AfricanAmerican |
2.064400E-02 |
| Caucasian-vs-Asian |
4.488800E-01 |
| AfricanAmerican-vs-Asian |
8.230100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.37639999900452E-08 |
| Normal-vs-Female |
9.819100E-04 |
| Male-vs-Female |
2.017400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.320100E-02 |
| Normal-vs-Extreme_Weight |
3.158600E-04 |
| Normal-vs-Obese |
1.371960E-04 |
| Normal-vs-Extreme_Obese |
8.064200E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.783800E-01 |
| Normal_Weight-vs-Obese |
4.021200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.913600E-01 |
| Extreme_Weight-vs-Obese |
3.727800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.154000E-01 |
| Obese-vs-Extreme_Obese |
6.025000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.988940E-04 |
| Normal-vs-Age(41-60Yrs) |
1.45150000019356E-07 |
| Normal-vs-Age(61-80Yrs) |
1.65746999999383E-05 |
| Normal-vs-Age(81-100Yrs) |
8.527800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.310400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.877190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.376600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.916600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.633970E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.696300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.83080012156256E-10 |
| Normal-VS-Type2 PRCC |
3.258000E-01 |
| Normal-VS-KIRP CIMP |
1.093910E-02 |
| Normal-VS-Unclassified PRCC |
1.516090E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.61512999999891E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.198000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.698800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.804900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.072410E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.267600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.893540E-02 |
| Normal-vs-N1 |
2.375600E-03 |
| Normal-vs-N2 |
7.773400E-01 |
| N0-vs-N1 |
7.287800E-02 |
| N0-vs-N2 |
5.362800E-01 |
| N1-vs-N2 |
2.163200E-01 |
|
|
